BRCA2 and ductal breast carcinoma in situ: In the BRCA2 mutation-related cases with DCIS and concomitant invasive cancer, 38% (6/16) of the cases HIF-1α expression was observed and was absent in 38% (6/16) of the cases (Table 4).